Regional Wait Times for Patients With Nonmelanoma Skin Cancer in Southwestern Ontario

What are wait times to see a specialist? an analysis of 26,942 referrals in southwestern Ontario.

BACKGROUND Reducing wait times is a key goal of Canadian health planners and policy makers. Using data from the EMRs of 23 family physicians across southwestern Ontario, we present data on wait times to see a specialist, and evaluate these data for equity. METHODS Cross-sectional analysis of EMR database of 29,303 patients and 544,398 encounters from October 2005 to July 2010. Wait time was c...

Primary malignancy in patients with nonmelanoma skin cancer-letter.

Hereditary nonmelanoma skin cancer.

Cutaneous basal and squamous cell carcinomas are among the most frequent malignancies in the white population, with the annual incidence estimates ranging from 1 million to 3.5 million cases in the United States. These tumors can occur either sporadically or in the context of hereditary genodermatoses with cancer predisposition, such as basal cell nevus syndrome, xeroderma pigmentosum, epidermo...

Nonmelanoma skin cancer.

Each year, there are as many cases of nonmelanoma skin cancer as all other cancers combined. Although there is relatively low attributable mortality, the morbidity and expense of treatment is significant. Unlike many other malignancies, host and environmental factors relevant to the pathophysiology have been clearly demonstrated. Surgical ablation remains the mainstay of treatment.

Factors associated with wait times across the breast cancer treatment pathway in Ontario

BACKGROUND Longer times from diagnosis to breast cancer treatment are associated with poorer prognosis. This study examined factors associated with wait times by phase in the breast cancer treatment pathway. METHODS There were 1760 women eligible for the study, aged 50-69 diagnosed in Ontario with invasive breast cancer from 1995-2003. Multivariate logistic regression examined factors associa...